A Study of YL201 in Combination With Other Anti-Cancer Therapies in Patients With Advanced Solid Tumors
MediLink Therapeutics (Suzhou) Co., Ltd.
MediLink Therapeutics (Suzhou) Co., Ltd.
Instituto Nacional de Cancerologia de Mexico
Casa di Cura Dott. Pederzoli
Turning Point Therapeutics, Inc.
Eli Lilly and Company
Chinese University of Hong Kong
George Washington University
VA Office of Research and Development
Revolution Medicines, Inc.
Fundación GECP